Tillotts Pharma AG

Subsidiary of Zeria Pharmaceutical Co., Ltd. (4559) · Switzerland

Assets

(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Approved
Glucocorticoid receptorSmall molecule
Inflammatory Bowel Disease
Crohn's Disease

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.